pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·Jul 19·1 min read
save

Abbott reports cyberattack on cancer diagnostics and LabCentral portal, says operations unaffected

Jul 19, 2026·read at Fierce Biotech ↗Negative

Abbott announced that a cyber incident on July 16 accessed a limited number of internal systems in its cancer diagnostics unit.

The company said the breach does not affect product availability, manufacturing, lab operations, or its ability to serve patients, and it expects no material impact on finances.

Abbott is working with law enforcement and third‑party cybersecurity experts to investigate and resolve the issue, and it continues to monitor its systems closely.

The attack also involved a third‑party facing LabCentral portal that contains publicly available information, which a hacker allegedly accessed according to Reuters.

source

This writeup was produced by pharmadog from original reporting by Fierce Biotech.

Original headline: “Abbott hit by cyberattack on cancer diagnostics, LabCentral portal businesses”

read at Fierce Biotech ↗
363 words · retrieved Jul 20
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Diagnostics Company9Medical Device Company8Oncology7

related stories

  • 4d agoGE HealthCare to acquire Sofie Biosciences for $945MBioPharma Dive
  • Oct 2Abbott launches SimpleScreen CRC blood test in the USFierce Biotech
  • Sep 24Grail multicancer detection test wins FDA advisers’ backingBioPharma Dive
  • Sep 24Grail survives adcomm vote as it awaits FDA decision for cancer blood testFierce Biotech
  • Sep 15Mayo Clinic teams with Thermo Fisher to form biomedical data group PrecureFierce Biotech